Targeting CBP revers chemoresistance to 5-FU of CDX2/REG4 double-positive gastric cancer.
Fan Z, Li F, Jiang X, Pan T, Zang M, Li J, Yu B, Sang Q, Liu W, Su L, Li C, Zhu Z, Yan M, Yan C, Yuan F, Liu B.
Fan Z, et al. Among authors: yan m.
Clin Transl Med. 2024 Nov;14(11):e70069. doi: 10.1002/ctm2.70069.
Clin Transl Med. 2024.
PMID: 39456121
Free PMC article.
No abstract available.